Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain

Affiliations

¹ Pain Research, Nuffield Department of Anaesthetics, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK Institut Gustave-Roussy, Département de Interdisciplinaire de Soins de Support, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France Laboratoires Grunenthal, 100-102 rue de Villiers, 92309 Levallois-Perret, France.

Review

Henry J McQuay et al. Pain. 2008 Apr.

. 2008 Apr;135(3):217-220.

doi: 10.1016/j.pain.2008.01.014. Epub 2008 Feb 6.

¹ Pain Research, Nuffield Department of Anaesthetics, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK Institut Gustave-Roussy, Département de Interdisciplinaire de Soins de Support, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France Laboratoires Grunenthal, 100-102 rue de Villiers, 92309 Levallois-Perret, France.

No abstract available

References

1. Dahlof CG, Pascual J, Dodick DW, Dowson AJ. Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials. Cephalalgia. 2006;26:400-408.
1. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118:289-305.
1. Freidlin B, Simon R. Evaluation of randomized discontinuation design. J Clin Oncol. 2005;23:5094-5098.
1. Fries S, Grosser T, Price TS, Lawson JA, Kapoor S, DeMarco S, et al. Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2. Gastroenterology. 2006;130:55-64.
1. Goadsby PJ, Massiou H, Pascual J, Diener HC, Dahlof CG, Mateos V, et al. Almotriptan and zolmitriptan in the acute treatment of migraine. Acta Neurol Scand. 2007;115:34-40.